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PERSPECTIVE
Paracrine factors for 
neurodegenerative disorders: special 
emphasis on Parkinson’s disease
The progressive loss of dopaminergic neurons in the ventral mesen-
cephalon is the main pathological hallmark of Parkinson’s disease (PD). 
Drugs currently available only alleviate the principal symptomatic 
motor-related disturbances and their benefit is counteracted by side ef-
fects in the long time. While cell replacement strategies for approaching 
PD by means of intrastriatal implantation of dopaminergic neurons 
showed some encouraging results in a number of patients this thera-
peutical approach aims primarily to replenish the lack of dopamine 
but not halting disease progression. Hence, over the past decades 
various strategies have been exploited to protect the dopaminergic 
neurons in the ventral mesencephalon from dying. Of special impor-
tance are in this context neurotrophic factors, drugs striving against 
oxidative stress and bioenergetic supplements. Particularly, several 
neurotrophic factors have been described to specifically increase the 
survival and/or growth of dopaminergic neurons in vitro and in vivo, 
including neurotrophins and glial cell line-derived neurotrophic fac-
tor (GDNF) family members. 
The use of stem cells for tissue regeneration elicited hope for the 
development of better treatment options for many neuropathological 
conditions. Indeed, in the last decade a considerable number of studies 
have been conducted to explore the potential of progenitor and stem 
cells. Importantly to note, in experimental stroke models significant 
improvement of symptoms was observed, however, histological ana-
lyzes revealed that only a small portion of transplanted cells differen-
tiated into mature neurons. Hence, the concept that these cells exert 
therapeutic actions by replacing defective cells by differentiating into 
multiple cell types has been gradually revised. It is now believed that 
the restorative effects observed in cell transplantation settings mainly 
rely on autocrine/paracrine activities (Andres et al., 2011). In line with 
this notion, improved tissue functionality is typically associated with 
low levels of cell engraftment and cell trans-differentiation (Drago et 
al., 2013). There is a general consensus that the trophic and immuno-
modulatory paracrine activities are not simple bystander but rather 
main players of tissue regeneration supported by progenitor/stem cells. 
Hence, in the present perspective we communicate on the composition 
and mechanisms of action of the factors secreted by stem/progenitor 
cells commonly defined as secretome (Liang et al., 2014).
The big variety of active elements released by cells can be tentatively 
classified in soluble factors and particulates. Classical growth factors 
and cytokines quantitatively predominate in the group of soluble fac-
tors that includes also lipids, extracellular matrix (ECM) com-ponents 
and nucleotides. Importantly to note, ECM components play an im-
portant role in juxtacrine signaling, however, in the present study we 
focus on its role in the secretome of stem/progenitor cells. The category 
of particulate factors is fundamentally composed of vesicular bodies, 
which are further distinguished in ectosomes and exosomes. Thereby, 
ectosomes range from 100 to 500 nm in diameter. Microvesicles arise 
from budding of the plasma membrane of a cell and their size range 
between 100 nm and 1,000 nm. Conversely, exosomes originate from 
an exocytosis process and are 30 nm to 100 nm sized (Anthony and 
Shiels, 2013). Microvesicles are important signaling mediators func-
tioning as cargoes of variety of bioactive materials including genetic 
material (mRNA, microRNA, rRNA, and tRNA) and lipids (Choi et al., 
2013). Interstingly, they can also shuttle mitochondria from one cell 
to the other (Spees et al., 2006). The importance of these particulates 
is highlighted by the fact that the portion of secreted proteins actually 
present both in microvesicles and exosomes may reach up 40% (Zullo 
et al., 2015) (Figure 1). Hence, it is important to note that a big variety 
of soluble factors and particulates are present in the secretome of stem/
progenitor cells.
Most of the current knowledge on the importance of soluble factors 
for preventing degeneration and promoting recovery has been gathered 
in studies using mesenchymal stem cells (MSC).
Different studies have provided indirect evidence that MSC mediate 
enhanced survival of nigral dopaminergic neurons and functional recov-
ery in a parkinsonian model of rats by means of secreted factors (Wang 
et al., 2010). Additionally, the use of conditioned medium (CM) has 
allowed investigating more precisely the potential of paracrine secretions 
for tissue repair/protection. In this respect, it has been demonstrated 
that CM derived from bone marrow MSC supports the viability of rat 
primary dopaminergic neurons while preconditioning with CM en-
hances the survival of transplanted dopaminergic neurons in an animal 
model of PD (Shintani et al., 2007). Moreover, MSC-derived CM has 
been described to exert neuroprotective effects in vitro on dopaminergic 
and serotoninergic cells against oxidative stress (Whone et al., 2012) 
with GDNF acting as a crucial mediator. Interestingly, the protein DJ-1 
whose gene mutations are closely associated with the development of 
PD, is protective for neuronal cells as well as primary dopaminergic neu-
rons challenged respectively by ischemia and neurotoxins (Mullett and 
Hinkle, 2009; Kaneko et al., 2014) and has been found to be secreted by 
MSC, astrocytes, and neuronal progenitor cells.
There is compelling evidence that the tissue regenerative properties 
of MSC do not rely solely on the trophic and anti-apoptotic functions 
of neurotrophic factors. It is in fact recognized that the chemotactic 
stromal cell-derived factor-1 α secreted by MSC promote endogenous 
repair through the activation of resident neuronal stem cells (NSC) 
(Wang et al., 2010). Moreover, stimulation of vascular growth by re-
leased soluble angiogenic factors is another relevant mechanism for the 
repair of ischemic tissues, but also for ameliorating the progression of 
tissue degeneration in Alzheimer’s disease (AD) and PD. Furthermore, 
the capacity to modulate the inflammation by paracrine factors is of 
outmost importance to steer neuronal tissues towards damage or re-
pair for all neurodegenerative conditions. In this respect, MSC secrete 
Figure 1 Schematic drawing of the major components in the secretome 
produced and released by various stem and progenitor cells.
Stem and progenitor cells produce a variety of factors that affect different 
functions of the targeted neurons. These bioactive proteins or lipids are either 
released free or in microvesicles and exosomes. Importantly, microRNA and or-
ganelles like mitochondria are part of the secretome. 
Figure 2 Photomicrographs of human midbrain cell cultures.
The human midbrain (ReNcell-VM) cell line was grown for 1 week in control 
medium (A) or exposed to endothelial progenitor cells (EPC)-derived condi-
tioned medium (B). The cultures were then immunocytologically stained for 
the neuronal marker beta-III-tubulin (in green) and the nuclear marker dapi (in 
blue). Note the higher fiber network of neuronal cells in the EPC-derived condi-
tioned medium treated cultures. Moreover, EPC-derived conditioned medium 
administration induced a dopaminergic phenotype as demonstrated by the pres-
ence of some tyrosine hydroxylase (TH; in red) positive neurons (inserts, boxed 
area in B). Scale bars: 50 μm.
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various pro- and anti-inflammatory molecules. These include not only 
cytokines but also lipids as sphingosine-1-phosphate (S1P) and pros-
taglandins and their metabolizing enzymes. Importantly, alterations in 
the S1P signalling have been associated to the pathogenesis of AD while 
S1P administration has demonstrated neuroprotective effects on exper-
imental models of AD and PD (Pyszko and Strosznajder, 2014).
Nucleotides and nucleosides constitute an important group of para-
crine messengers involved in cell growth/differentiation and immuno-
modulation in a number of physiological and pathological conditions 
(Cavaliere et al., 2015). Given that MSC and NSC release purines and 
express the purinergic receptors and ectonucleotide metabolizing 
machinery, it has been proposed that extracellular purines might be 
considered a valuable tool to promote neuronal tissue homeostasis 
and repair (Cavaliere et al., 2015). Furthermore, MSC and endothelial 
progenitor cells (EPC) secretomes are rich of ECM elements like hepa-
ran or chondroitin sulfate proteoglycans as well as metalloproteinases. 
In addition to the essential role in growth factor signaling and syn-
aptic transmission, ECM directly modulates plasticity. So, a number 
of proteins, as for example SPARC and Cyr61 that bind to ECM, are 
important regulators of cellular functions (Estrada et al., 2009). These 
so called matricellular proteins are important constituents of the MSC 
secretome. It is thus not surprising that an altered ECM composition 
is involved in the development of many neurodegenerative disorders 
including AD, epilepsy and schizophrenia. 
It is now well established that exosomes can exert cytoprotective ef-
fects. This phenomenon has been observed also for dopaminergic cells 
incubated with exosomes derived from MSC (Jarmalaviciute et al., 2015). 
A growing amount of observations have shown that the genetic transfer 
through mRNAs and/or miRNAs carried by microvesicles and exosomes 
is a crucial element in cell-to-cell communication and instructs both 
degenerative and reparative processes. The list of miRNA shuttled by 
the vesicles according to the cells of origin and the disease states is con-
tinuously updated and represents an extraordinary biological tool to 
harness tissue repair (Smith et al., 2015).
It is clear that the effects exerted by secretomes are likely the result 
of a interplay of multiple factors with a different biochemical nature 
including proteins, lipids, and nucleic acids, activating different down-
stream events at the cellular level. Due to this heterogeneous mode of 
action and assorted composition, predictions of targeted cell popula-
tions are challenging. Nevertheless, given that many of the factors pres-
ent in the secretomes are finally dependent on their specific receptors 
to be operative multireceptor mapping may offer a novel tool for the 
identification of such targets.
Studies from our laboratory have shown that the secretome derived 
from EPC promotes angiogenesis, resistance against oxidative stress in 
endothelial cells but also the dif-ferentiation of neuronal stem/progen-
itor cells. Importantly to note in the context of PD, is the potential of 
EPC-derived CM to induce a dopaminergic phenotype in neurons of 
midbrain cultures (Figure 2). These effects which are mediated by pro-
teinaceous and lipid factors are paradigmatic of pleiotropic actions of 
the secretome (Di Santo et al., 2016).
The use of secretome originated from different cell types is emerging 
in the field of tissue repair/regeneration due in part to advantages over 
cell transplantation. Notably, secretome-based therapies pose few con-
cerns with regards to immunogenic reactions and oncogenicity. These 
features offer the advantage of an allogenic and off the shelf use. Thus, 
in consideration of the high scalability and the possible, countless mod-
ifications, secretomes can be considered an ideal interface between cell-
based therapies and conventional drugs. It is, however, important to 
note that secretome-based approaches have also limitations and draw-
backs. In addition to beneficial effects, the variety of active factors that 
can be found in secretomes can promote tissue fibrosis or even elicit 
inflammatory responses. Moreover, it has been reported that secre-
tomes derived from senescent cells can in turn propagate senescence in 
neighbor cells; a phenomenon termed senescence associated secretory 
phenotype (Zullo et al., 2015).
In sum, the detailed characterization of the different secretomes 
including mechanisms of action will be an important topic for the full 
exploitation of their tissue regenerative potentials. Thus, new studies 
are needed to overcome the current limitations of secretome-based 
treatments and to achieve alternative and/or complementary therapeu-
tic tools for neurodegenerative disorders.
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